Fecal Transplants Safe, Effective Treatments for All C. Diff Patients
The study eases concerns about using fecal transplants in patients with compromised immune systems, for which supporting guidelines and data did not previously exist.
Lead researcher Chioma Ihunnah, MD, of Brown University in Providence, R.I., and her team found the cure rate of C. diff with a single fecal transplant to be 79 percent, which rose to 89 percent after a second transplant.
More Articles on Gastroenterology:
IBD Sufferers Often Have Limited Access to Care
Olympus Medical to Launch Updated Ultrasound Endoscopy Center in November
South Jersey Endoscopy Center Purchases HET System for Hemorrhoid Treatment
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- How Physician Thinking Changes After Working in ACOs
- 2014 Financial Impact Analysis Doesn't Stop With CMS' Final Rule: Don't Neglect CMS NCCI Edits
- 4 Drivers of Recent M&A Activity in Healthcare
- 8 Reasons to Outsource Medical Billing Services
- 5 ICD-10 Transition Considerations Medical Practices Have Likely Not Thought About